Relative Bioavailability Study of HR19042 in Healthy Subjects

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
This is a single-center, randomized, open-label, three-period, dual Latin square crossover study. Primary Objective: 1. To evaluate the oral relative bioavailability of HR19042 Capsules compared with budesonide delayed-release capsules (Tarpeyo®) and budesonide enteric-coated capsules (Budenofalk®). Secondary Objective 2. To assess safety following administration.
Epistemonikos ID: 558ffcebc78132ba1b2555a5a1151afdac3d5437
First added on: Apr 11, 2025